Mefluleucine (INN; developmental code names NV-5138, SPN-820) is an investigational new drug that is being evaluated by Navitor Pharmaceuticals and Supernus Pharmaceuticals for the treatment of major depressive disorder (MDD).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.